GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC30705 structure
    GC30705Veledimex S enantiomer (INXN-1001 S enantiome)
    CAS: 1093131-03-3
    Purity: >99.50%

    L'énantiomère Veledimex S (énantiomère INXN-1001 S) est l'énantiomère S du veledimex. Veledimex est un ligand activateur oral pour un système propriétaire de promoteur de thérapie génique, et un inhibiteur modéré et un substrat du CYP3A4/5.

  • GC30774 structure
    GC30774Tat-NR2B9c
    CAS: 500992-11-0
    Purity: >98.00%

    Tat-NR2B9c est un inhibiteur de la densité postsynaptique-95 (PSD-95), avec des valeurs d'EC 50 de 6.7nM et 670nM pour PSD-95d2 et PSD-95d1, respectivement.

  • GC30806 structure
    GC30806Cyclo(his-pro) (Cyclo(histidyl-proline))
    CAS: 53109-32-3
    Purity: >98.00%

    Cyclo(his-pro) (Cyclo(histidyl-proline)) est un dipeptide cyclique endogène, perméable à la barrière hémato-encéphalique, dérivé du catabolisme de l'hormone de libération de la thyrotropine (TRH).

  • GC30831 structure
    GC30831GIBH-130
    CAS: 1252608-59-5
    Purity: >99.50%

    GIBH-130 est un inhibiteur efficace de la neuroinflammation.

  • GC30910 structure
    GC30910Eucalyptol (1,8-Cineole)
    CAS: 470-82-6

    A bicyclic monoterpene with diverse biological activities

  • GC31243 structure
    GC31243S-MTC
    CAS: 156719-41-4
    Purity: >98%

    Le S-MTC est un inhibiteur sélectif de l'oxyde nitrique synthase (NOS) de type I.

  • GC31272 structure
    GC31272Isosteviol ((-)-Isosteviol)
    CAS: 27975-19-5
    Purity: >98.00%

    L'isostéviol ((-)-Isosteviol) ((-)-Isosteviol ((-)-Isosteviol)) est un dérivé du stévioside par hydrolyse catalysée par un acide du stévioside.

  • GC31290 structure
    GC312903-Indolepropionic acid
    CAS: 830-96-6
    Purity: >99.50%

    L'acide 3-indolepropionique s'est avéré être un puissant antioxydant et a un potentiel dans le traitement de la maladie d'Alzheimer.

  • GC31292 structure
    GC31292Mitoquinone mesylate (Mitoquinone methanesulfonate)
    CAS: 845959-50-4
    Purity: >98.00%

    Mitoquinone mesylate (Mitoquinone méthanesulfonate) est l'un des antioxydants les plus utilisés qui ciblent les mitochondries.

  • GC31312 structure
    GC31312RCGD423
    CAS: 108237-91-8
    Purity: >99.50%

    RCGD423 est un modulateur gp130, qui prévient la dégénérescence du cartilage articulaire et favorise la réparation.

  • GC31319 structure
    GC31319Amlexanox (AA673)
    CAS: 68302-57-8
    Purity: >99.50%

    Amlexanox (AA673), un acide aminocarboxylique tricyclique à activité orale, peut inhiber efficacement la kinase 1 liant TANK (IC 50 = 0.8μM) et la kinase epsilon inhibiteur-kappaB (IKK-ɛ) (IC 50 = 5.8μM).

  • GC31321 structure
    GC31321KI696
    CAS: 1799974-70-1
    Purity: >99.00%

    KI696 est une sonde de haute affinité qui perturbe l'interaction Keap1/NRF2.

  • GC31350 structure
    GC31350Astaxanthin
    CAS: 472-61-7
    Purity: >98.00%

    L'astaxanthine, le caroténoÏde alimentaire rouge, est un antioxydant efficace et puissant par voie orale.

  • GC31353 structure
    GC31353Glutathione oxidized (L-Glutathione oxidized)
    CAS: 27025-41-8
    Purity: >99.00%

    Glutathione oxidized (L-Glutathione oxidized), une forme oxydée du glutathion L-antioxydant, agit comme une molécule de signalisation qui déclenche l'activation des gènes antioxydants.

  • GC31364 structure
    GC31364Fucoxanthin (all-trans-Fucoxanthin)
    CAS: 3351-86-8
    Purity: >98.00%

    Fucoxanthin (all-trans-Fucoxanthin) est un caroténoïde naturel qui est largement distribué dans les algues brunes comestibles et les diatomées.

  • GC31377 structure
    GC31377Tofogliflozin hydrate (CSG-452 hydrate)
    CAS: 1201913-82-7
    Purity: >98.00%

    L'hydrate de tofogliflozine (hydrate de CSG-452) est un inhibiteur puissant et hautement spécifique du cotransporteur sodium/glucose 2 (SGLT2) avec une IC50 de 2,9 nM et des valeurs Ki de 2,9 nM, 14,9 nM et 6,4 nM pour le SGLT2 humain, de rat et de souris .

  • GC31391 structure
    GC31391Kuwanon A
    CAS: 62949-77-3
    Purity: >98.00%

    Kuwanon A est un dérivé de flavone isolé des écorces de racine du mÛrier (Morus alba L.

  • GC31511 structure
    GC31511Sinapinic acid (Sinapic acid)
    CAS: 530-59-6
    Purity: >99.50%

    L'acide sinapinique (acide sinapique) (acide sinapique) est un composé phénolique isolé de Hydnophytum formicarum Jack.

  • GC31557 structure
    GC31557Edasalonexent (CAT-1004)
    CAS: 1204317-86-1
    Purity: >98.00%

    Edasalonexent (CAT-1004) (CAT-1004) est un inhibiteur NF-κB biodisponible par voie orale.

  • GC31639 structure
    GC31639Dexamethasone (Hexadecadrol)
    CAS: 1177-87-3
    Purity: >98%

    An acetate form of dexamethasone

  • GC31642 structure
    GC31642SN50
    CAS: 213546-53-3
    Purity: >98.00%

    SN50, le peptide inhibiteur perméable aux cellules ciblant NF-κB.

  • GC31644 structure
    GC31644MCC950 (CP-456773)
    CAS: 210826-40-7
    Purity: >98.00%

    MCC950 (CP-456773) (CP-456773; CRID3) est un inhibiteur puissant et sélectif de NLRP3 avec des IC50 de 7,5 et 8,1 nM dans les BMDM et les HMDM, respectivement.

  • GC31645 structure
    GC31645YKL-05-099
    CAS: 1936529-65-5
    Purity: >99.50%

    YKL-05-099 est un inhibiteur de petites molécules hautement sélectif des kinases inductibles par le sel (SIK1: IC 50 = 10nM; SIK2: IC 50 = 40nM; SIK3: IC 50 = 20nM).

  • GC31647 structure
    GC31647Tomatidine
    CAS: 77-59-8
    Purity: >98.00%

    La tomatidine agit comme un agent anti-inflammatoire en bloquant la signalisation NF-κB et JNK.